Логин: Пароль: ?
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное


Наши партнеры:



What may be of interest to the Lithuanian experience of expanding the possibilities of modern hemp breeding for Ukraine


The bill regulates the possibilities for the extraction and processing of therapeutic hemp by technical equipment in Lithuania and allows products containing drug-free cannabinoids to be imported, exported and sold to consumers .  Now we are multiplying the possibilities of Lithuania , Holland , Czech Republic , Germany , Poland , Great Britain , USA , Canada , as well as a number of other economically developed countries for several yearsspecializing in the production of cannabinoid products , which include drug-free cannabinoids and ask ourselves the elementary question - what will happen to the domestic market of Ukraine , if we allow the sale of CBD products , which include up to 0.2% THC.  

In 2014, in Lithuania at the level of the law has regulated the possibility of cultivation of cannabis plants in the industrial purposes. Due to the fact that the country is a member of the EU , agricultural producers were allowed to grow only industrial hemp varieties , entered in the register of varieties of the European Union , the amount of tetrahydrocannabinol (THC) which does not exceed 0.2%. 

Since regulating the legitimacy of cultivation of industrial hemp in the country, a significant number of farmers have been growing hemp plants as an alternative to traditional crops . The rapid dynamics of the cultivation of the most profitable agricultural crops has led to the fact that the small Baltic state at the moment already plays a significant role in European hemp breeding .

The norms of the current legislation of Lithuania suggest that the plant is grown to produce seeds and fiber (an ultramodern plant for the deep processing of straw / trusts and hemp fiber of textile quality has been built ), and the processing of leaves and inflorescences of the plant is currently not allowed on an industrial scale (the study of properties is regulated hemp plant leaves and inflorescences exclusively by scientific institutions ). This means that the Lithuanian agricultural producers , specializing in the cultivation of cannabis plants to produce green mass rich beznarkoticheskimi cannabinoids can sell grown raw materials exclusively abroad. In particular, Lithuanian farmers were active in 2018-2019. sold cultivated leaves and inflorescences of technical hemp of a therapeutic orientation to Poland , Germany , Switzerland and the Czech Republic . 

The peculiarity of the 2019 season is that, on the one hand, a significant amount of therapeutic green hemp cultivated plants of therapeutic hemp varieties predetermined a crisis of overproduction , on the other hand, the regulatory framework does not allow the extraction of plants in order to obtain a high value-added product , which in the future can be used for the manufacture of highly liquid cannabinoid products on the territory of Lithuania itself .

Understanding the processes occurring in the industry , government officials have initiated changes to the current legislation of the country , regulating the possibility of legal extraction of leaves and inflorescences of industrial hemp therapeutic orientation in an industrial scale . It should be noted that a number of Lithuanian entrepreneurs, realizing the inevitability of amendments to the current legislation, initiated the creation of appropriate facilities for the extraction of plants and the production of concentrates (isolates) or semi-finished products, which can later be used for the production of extracts or final products containing drug-free cannabinoids .

Features of the novels of the law adopted in Lithuania :

• agricultural producers , as well as hemp plant processors who have drawn up the necessary permits for this, will be able to process all parts of the plant , including leaves and inflorescences ;

•  any end product from industrial hemp containing less than 0.2% tetrahydrocannabinol in its composition can be produced , exported, imported or sold to customers in Lithuania without any restrictions.

In numerous interviews with the media, Lithuanian government officials emphasized that "a country cannot be an exporter of cheap biomass for a long time , but should focus on processing cannabis , including therapeutic ones , as well as creating high value-added products ."

Commentary experts of the Association "Ukrainian industrial hemp"

Given the strong demand on the leaves and inflorescence industrial hemp therapeutic orientation of agricultural producers in Lithuania in 2019 dramatically increased the number of crop varieties of hemp plants , possess therapeutic properties , but the amount of THC which does not exceed the permissible EU levels in the 0.2% THC. The year was a landmark for the industry , since about half of the industrial crops were occupied by varieties with therapeutic properties , and the resulting raw materials were planned to be exported to other EU countries where extraction is allowed.

Since January 2019, Lithuanian lawmakers have made significant progress in matters related to the revision of the current regulatory framework regarding hemp processing capabilities . The relevant  draft law regulates the possibilities for the extraction and processing of therapeutic hemp in Lithuania and allows products containing drug-free cannabinoids to be imported, exported and sold to consumers . 

The bill passed the first and second votes in the Sejm of the Republic of Lithuania . On the eve of the third and final vote, scheduled for April, the Legal Department of the Parliament raised the issue of compatibility of the relevant Lithuanian legislation with the EU regulatory framework . In this regard, the Committee on Agriculture of the Parliament of the country announced that parliamentarians are "taking a break" in their work and are sending the above bill to the EU headquarters for consideration. Using the notification procedure of the European Union , Lithuania initiated a minimum three-month freeze on the adoption of the aforementioned draft law in order to allow the European Commission and other EU Member States to study the bill and respond to the possibility of its adoption.

Given the destruction of its own seed and breeding base , the following foreign therapeutic hemp varieties of therapeutic hen are grown in Lithuania : 

rich in cannabidiol - Finola, Fedora, Futura, Felina;

- rich in cannabigerol - Santhica.

In the process of norm-setting , Lithuania is at least several years ahead of Ukraine in the field of regulating the possibility of extracting therapeutic therapeutic hemp leaves and technical inflorescences . Government officials of this Baltic state are primarily thinking about developing their own hemp market . One of the key provisions laid down in the draft law is the possibility of production and sales of final products containing not more than 0.2% of TGK. Now we are multiplying the possibilities of Lithuania , the Netherlands , the Czech Republic , Germany , Poland , Great Britain , the USA , Canada , as well as a number of other economically developed countries, which have been specializing in the production of cannabinoid products for several years , which includes drug-free cannabinoids and ask ourselves an elementary question - what will happen to the domestic market of Ukraine , if allowed to sell CBD goods , which include up to 0.2% of TGK. 

Alternatively, it makes sense to think about what happens if you adopt only a departmental order , in which legal will in our country the production of products from the leaves and inflorescences of industrial hemp therapeutic orientation , the amount of THC which does not exceed 0.08% made methods excluding extraction. Studies by not only Ukrainian scientists suggest that the effectiveness of therapeutic products from the leaves and inflorescences of technical hemp, in which the amount of THC does not exceed 0.08%,  exceeds that produced from raw materials with 0.2% THC, since the biological properties of drug-free cannabinoids work as a compensator for the negative effects of tetrahydrocannabinol on the body . Moreover, extraction leads to a decrease in the biologically active properties of the plant and the inability to use the “ensemble effect” of drug-free cannabinoids , which works extremely efficiently when using non-extraction “green mass” . 

Обучение в рамках "Конопляного Университета"

Все объявления »